# USPIO-enhanced and Diffusion-weighted MRI for the Detection of Pelvic Lymph Node Metastases

> **NCT00622973** · PHASE3 · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 130 (actual)

## Conditions studied

- Prostate Cancer
- Bladder Cancer

## Interventions

- **OTHER:** Imaging: diffusion-weighted MRI
- **OTHER:** Sinerem (USPIO) enhanced MRI

## Key facts

- **NCT ID:** NCT00622973
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2011-10-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00622973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00622973, "USPIO-enhanced and Diffusion-weighted MRI for the Detection of Pelvic Lymph Node Metastases". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00622973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*